New hope for elderly brain cancer patients: shorter, gentler treatment tested
NCT ID NCT04765514
First seen Feb 16, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study is for people aged 65 and older with a newly diagnosed aggressive brain cancer called glioblastoma who are too frail for standard long treatments. It compares chemotherapy alone to chemotherapy plus radiation to see if the chemo-only approach works just as well with fewer side effects. About 107 participants will be randomly assigned to one of the two treatment groups and followed for up to 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arthur J.E. Child Comprehensive Cancer Center (formerly Tom Baker Cancer Centre)
TERMINATEDCalgary, Alberta, Canada
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.